Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors

Utilizing T cells expressing chimeric antigen receptors (CARs) to identify and attack solid tumors has proven challenging, in large part because of the lack of tumor-specific targets to direct CAR binding. Tumor selectivity is crucial because on-target, off-tumor activation of CAR T cells can result...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosti, Paris, Opzoomer, James W., Larios-Martinez, Karen I., Henley-Smith, Rhonda, Scudamore, Cheryl L., Okesola, Mary, Taher, Mustafa Y.M., Davies, David M., Muliaditan, Tamara, Larcombe-Young, Daniel, Woodman, Natalie, Gillett, Cheryl E., Thavaraj, Selvam, Maher, John, Arnold, James N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080111/
https://www.ncbi.nlm.nih.gov/pubmed/33948568
http://dx.doi.org/10.1016/j.xcrm.2021.100227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080111/
https://www.ncbi.nlm.nih.gov/pubmed/33948568
http://dx.doi.org/10.1016/j.xcrm.2021.100227

Ejemplares similares